1. Home
  2. VVX vs HRMY Comparison

VVX vs HRMY Comparison

Compare VVX & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo V2X Inc.

VVX

V2X Inc.

HOLD

Current Price

$74.99

Market Cap

2.3B

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$36.84

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VVX
HRMY
Founded
2014
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.2B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
VVX
HRMY
Price
$74.99
$36.84
Analyst Decision
Hold
Buy
Analyst Count
8
9
Target Price
$69.88
$44.11
AVG Volume (30 Days)
601.4K
768.4K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
126.85
7.97
EPS
0.60
0.55
Revenue
$4,480,038,000.00
$868,453,000.00
Revenue This Year
$7.81
$19.75
Revenue Next Year
$5.84
$12.88
P/E Ratio
$126.03
$69.47
Revenue Growth
3.65
21.51
52 Week Low
$46.27
$25.52
52 Week High
$91.80
$40.87

Technical Indicators

Market Signals
Indicator
VVX
HRMY
Relative Strength Index (RSI) 44.86 58.67
Support Level $65.02 $35.05
Resistance Level $78.36 $39.12
Average True Range (ATR) 4.00 1.23
MACD -0.51 0.13
Stochastic Oscillator 27.11 60.10

Price Performance

Historical Comparison
VVX
HRMY

About VVX V2X Inc.

V2X Inc is a U.S.-based company that provides services to the U.S. government. It operates as one segment and offers facility and logistics services and information technology mission support and engineering and digital integration services. The information technology and network communications capabilities consist of communications systems operations and maintenance, management and service support, systems installation and activation, system-of-systems engineering and software development, and mission support for the department of defense. The facility and logistics service include airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, and others.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: